February 10, 2011 – For the first time in the UK, cancer patients are starting to receive treatment with Novalis Tx radiosurgery. This device, by Brainlab and Varian Medical Systems, gives the chance of a cure to those with inoperable tumors and offers the possibility to perform precise, painless treatment in a single patient visit.

The system makes it possible for doctors to treat patients with tumors virtually anywhere in the body in just a single session. Combining a 'sat nav' like targeting system and powerful treatment beams, it can destroy cancerous cells and helps to protect surrounding healthy tissue. Treatment is also made more patient-friendly by delivering frameless radiosurgery for brain tumors, an alternative to techniques that require immobilization with an invasive head ring that is affixed to the skull.

In its first year of operation at the brand new Clatterbridge Cancer Centre in Liverpool, it is expected to treat more than 800 cancer patients. It is estimated that 150 of these patients will be priority brain tumor patients where precise, non-invasive treatment is particularly effective.

"Unlike some other highly specialized radiation treatment machines, the Novalis Tx can treat many different types of cancer in all over the body allowing us to treat more cancer patients with a single device,” said Brian Haylock, consultant oncologist and clinical director for radiotherapy at Clatterbridge Centre for Oncology. “This coupled with the speed with which we can treat patients - in some cases in as little as 15 minutes in just one session - means the equipment will be available for the benefit of more patients here in the UK."

Later this year, Novalis Tx machines will become operational at two other specialist NHS cancer centers in Edinburgh and Manchester.

For more information: www.brainlab.com, www.varian.com


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now